立即開始
Carr

Buy BLUE

看多
bluebird bio, Inc. (NASDAQ:BLUE)  
Carr  
NASDAQ:BLUE   bluebird bio, Inc.
1
0
Shares of biotech Bluebird are bouncing back after a misreading of clinical data sent the stock into a 2 day selloff. Bullish base is about to break to upside.

相關想法

Carr
RDN about to most up sharply
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。